Changes in the immune system in depression and dementia: Causal or co-incidental effects?

International Journal of Developmental Neuroscience

Volumn 19, Issue 3, 2001, Pages 305-312

  Leonard, Brian E ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Alzheimer's disease; Antidepressants; Depression; Nonsteroidal anti inflammatory drugs; Pro inflammatory cytokines

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTIDEPRESSANT AGENT; CYCLIC AMP; CYTOKINE; DESIPRAMINE; GLUCOCORTICOID; IMIPRAMINE; IMMUNOMODULATING AGENT; INTERLEUKIN 1; INTERLEUKIN 6; MONOAMINE; NITRIC OXIDE; OXYGEN RADICAL; PAROXETINE; REACTIVE OXYGEN METABOLITE; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR ALPHA; VENLAFAXINE;

ALZHEIMER DISEASE; BRAIN FUNCTION; CEREBROSPINAL FLUID; CONFERENCE PAPER; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEPRESSION; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STRESS;

ADJUVANTS, IMMUNOLOGIC; ALZHEIMER DISEASE; ANIMALS; ANTIDEPRESSIVE AGENTS; CYTOKINES; DEPRESSIVE DISORDER, MAJOR; HUMANS;

EID: 0035030335     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(01)00014-4     Document Type: Conference Paper

References (61)

1. An intracerebral tumor necrosis factor alpha infusion model for inflammation in Alzheimer's disease
2. Tumor necrosis factor alpha augments amyloid beta-protein (25-35) induced apoptosis in human cells
3. The role of antiinflammatory drugs in the prevention and treatment of Alzheimer's disease
4. Depression, immunocompetence and prostaglandins of the E series
5. Induction by lipoolysaccharide of cycloxygenase-2 mRNA in rat brain: its possible role in fabrile response
6. Tumour necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal cell cultures
7. Depression, stress and immunological activation: the role of cytokines in depressive disorders
8. An assessment of the effects of central interleukin-1 beta, -2, -6 and tumour necrosis factor-alpha administration on some behaviour, neurochemical, endocrine and immune parameters in the rat
9. Olfactory bulbectomy provokes a suppression of interleukin 1 beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: effect of chronic desipramine treatment
10. Interleukin-1 receptors in the brain and endocrine tissue
11. Stress and immunity: an integrated view of relationship between the brain and the immune system
12. Lentrivirus infection, immune response peptides and sleep
13. Immunological effects of neuropsychiatric substances
14. Microglia and cytokines in neurological disease with special reference to AIDS and Alzheimer's disease
15. The role of interleukin-1 and tumour necrosis factor-alpha in the neurochemical and neuroendocrine responses to endotoxin
16. Cerebral amyloid plaques in Alzheimer's disease but not in scrapie-affected mice are closely associated with local inflammatory process
17. Intravenous lipopolysaccharide induces cyclooxygenase 2-like activity in rat brain perivascular microglia and meningeal macrophages
18. Cytokines
19. Are cytokines associated with neuropsychiatric syndromes in humans?
20. Antidepressants and hypothalamic-pituitary-adrenocortical regulation
21. Cytokines and the nervous system: actions and mechanisms
22. The role of prostaglandins and prolactin in depression, mania and schizophrenia
23. Reduction of immune function in life stress and depression
24. Corticosterone modulates behavioural and metabolic effects of lipopolysaccharide
25. The olfactory bulbectomized rat model of depression: an update
26. Inflammation-associated amyloidogenesis
27. Effect of chronic treatment with imipramine on IL-1 and IL-2 production by splenocytes obtained from rats subjected to chronic mild stress model of depression
28. Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-gamma and interleukin-10
29. Stress, the immune system and mental illness
30. Stress, depression and the immune system
31. Pathways and mechanisms for cytokine signalling of the central nervous system
32. CSF prostaglandins levels in depressed and schizophrenic patients
33. Interleukin-1-beta: a putative mediator of HPA axis hyperactivity in major depression
34. The monocyte and T-lymphocyte hypothesis of major depression
35. Immune and clinical correlates of psychological stress-induced production of interferon-gamma and IL-10 in humans
36. Effect of beta-amyloid peptides on neurons in hippocampal slice cultures
37. Beta-amyloid induced toxicity in rat hippocampus cells: in vitro evidence for the involvement of free radicals
38. Cellular signalling roles of TGF-beta, TNF-alpha and bAPP in brain injury responses and Alzheimer's disease
39. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease; a review of 17 epidemiological studies
40. Induction of cytokines in glia cells surrounding cortical beta-amyloid plaques in transgenic Tg 2576 mice with Alzheimer pathology
41. Bone mineral density in women with depression
42. Exposure to acute stress induces brain interleukin-1 beta protein in the rat
43. Cyclooxygenase 2 nRNA expression in rat brain after peripheral injection of lipopolysaccharide
44. The Nobel chronicles. 1927: Julius Wagner-Jauregg (12857-1940)
45. Regulation of the human serotonin transporter by interleukin-12 beta
46. Intracerebral beta-amyloid produces tissue damage: is it neurotoxic?
47. Hypothalamic prostaglandin E2 during lipopolysaccharide-induced fever in guinea pigs
48. Differential effects of chronic antidepressant treatments on lipoplysaccharide-induced depressive-like behavioural symptoms in the rat
49. DNA damage induced by tumour necrosis factor-alpha in L929 cells is mediated by mitochondrial oxygen radical formation
50. Cognitive impairment in Alzheimer's disease correlates with ventricular atrophy-corrected glucose metabolism
51. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine
52. Indicators of immune activation in major depression
53. Stress and antibody response in rats
54. Serotonin reuptake inhibitors reverse the impairments in behaviour, neurotransmitter and immune function in the olfactory bulbectomized rat
55. The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression
56. Induction of interleukin-1 beta and interleukin-1 receptor antagonist nRNA by chronic treatment with various psychotropics in widespread areas of the brain
57. TCA's inhibit IL-I, IL-6 and TNF release in human blood monocytes and IL-2 and interferon in T-cells
58. Endotoxin produces a depressive-like episode in rats